Synthesis of alkyne-substituted tetrazine 2

2-(4-(1,2,4,5-tetrazin-3-yl)phenyl)acetic acid (S2)
Tetrazine phenyl acetic acid (S2, CAS: 1380500-92-4) is a commercial product. Conversely, it can be prepared according to the following procedure: To the mixture of 2-(4cyanophenyl)acetic acid S1 (687 mg, 4.27 mmol), nickel triflate (269 mg, 0.75 mmol), sulfur (136 mg, 4.27 mmol), formamidine acetate (4.44g, 42.7 mmol) was added anhydrous hydrazine (6.70 ml, 214 mmol, prepared by drying hydrazine monohydrate using flamed dried 3Å molecular sieves overnight) and stirred at 30ºC for 24 h under nitrogen atmosphere. The reaction mixture was transfered to 500ml glass beaker and sodium nitrite solution (15.3 g, 222 mmol) in water (45 ml) was added to the reaction mixture followed by 1M HCl until gas evolution ceased and the pH reached 3. The mixture was extracted with CH 2 Cl 2 and the organic phase was washed with brine, dried over sodium sulfate, filtrated and concentrated in vacuo. The residue was purified by silica gel column chromatography (CH 2 Cl 2 :MeOH=50:1) to obtain S2 as a red solid (429 mg, 47%). NMR data for this compound matched literature report. [1] 
2-(4-(1,2,4,5-tetrazin-3-yl)phenyl)-N-(prop-2-yn-1-yl)acetamide (2)
To a solution of S2 (100 mg, 0.46 mmol), 2,6-lutidine (107 µl, 0.92 mmol) in dry DMF (3 ml) was added HATU (350 mg, 0.92 mmol) and the reaction mixture was stirred for 5 min at 0 ºC under nitrogen atmosphere. Propargyl amine (68 µl, 1.06 mmol) was then added and the reaction was stirred for 2 h at 0 ºC. Saturated sodium bicarbonate solution was added to the reaction mixture and the product was extracted with CH 2 Cl 2 . The organic phase was washed with brine, dried over sodium sulfate, filtrated and concentrated in vacuo. The residue was purified by silica gel column chromatography (CH 2 Cl 2 :MeOH=100:1) furnishing 2 as a red solid (95 mg, 82%). 
Preparation of azide-glycan 1
General procedures
Azido glycan 1 were prepared according to the procedure reported by Shoda et al. [2] Briefly, a mixture of reducing glycan 4, Et 3 N, 2-chloro-1.3-dimethylimidazolium chloride (DMC), NaN 3 , in 1,4-dioxane/ H 2 O=1/1 was stirred for 1 h at -10 ºC. The solvent was evaporated and the residue was purified directly by column chromatography. In some cases, it was found to be more practical to transiently acetylate the product for purification purposes. For convenience, the reactions were also performed in D 2 O which facilitates reaction monitoring by NMR. In a 2.0ml Eppendorf tube, glycan 4, NaN 3 , 2-chloro-1.3-dimethylimidazolium chloride (DMC), and Et 3 N or 2,6-lutidine were added to D 2 O. The mixture was shaken vigorously until the mixture became homogeneous. The mixture was then transferred to an NMR tube and the progress was monitored by H 1 -NMR with intermittent shaking. Upon completion, the reaction was transferred back to the Eppendorf and lyophilized.
To the residue was added Ac 2 O (300 µl) and pyridine (1 ml) and the reaction mixture was stirred overnight at room temperature. The reaction was concentrated in vaccuo and the product was isolated by reverse phase chromatography (12g of C18 column, 50 ml of H 2 O, then 100 ml of acetonitrile). The acetonitrile fraction was concentrated in vacuo then lyophilized. To the residue was added sodium methoxide (6 mg, 0.1 mmol) and dry methanol. The reaction mixture was stirred overnight under nitrogen atmosphere. The reaction mixture was neutralized with acidic resin (DOWEX ® 50WX2), filtered and lyophilized.
After filtration, the mixture was concentrated in vacuo and the residue was purified by reverse phase column (12g of C18 column, flowed 200 ml of H 2 O ). Lyophilizing solvent gave desired azide-suger.
The mixture was then tra 1 M NaOH (100 µl) and stirred 3 h. 
β-D-Glucopyranosyl azide (1a)
D-Galactopyranosyl azide (1c)
D-Galactose (54 mg, 0.3 mmol), DMC (153 mg, 0.9 mmol), NaN 3 (291 mg, 4.5 mmol), triethylamine (375 µl, 2.7 mmol) in deutrium oxide (1.2 ml) were shaken for 1 h at room temperature to afford a mixture of α and β anomers. The solvent was evaporated in vacuo and to the residues were treated with Ac 2 O (900 µl) and pyridine (3 ml). After stirring overnight at room temperature, the solvent was removed in vacuo and the residues were purified by silica gel column chromatography (Pentane:EtOAc=10:1) to separate α and β anomers. Each anomer was dissolved in dry methanol (1 mL) and treated with sodium methoxide (6 mg, 0.1 mmol). The reaction mixture was stirred overnight under nitrogen atmosphere. The mixture was neutralized with acidic resin (DOWEX ® 50WX2), diluted with water (5 mL) and lyophilized to obtain α-D-Galactopyranosyl azide (9 mg, 15%) as colorless solid and β-D-Galactopyranosyl azide (33 mg, 53%) as colorless solid. Spectral characteristics of this compound matched the reported data. [3] α 
L-Fucopyranosyl azide (1d)
L-Fucose (48 mg, 0.3 mmol), DMC (153 mg, 0.9 mmol), NaN 3 (291 mg, 4.5 mmol), triethylamine (375 µl, 2.7 mmol) in deutrium oxide (1.2 ml) were shaken for 1 h at room temperature. The solvent was evaporated in vacuo and to the residues were treated with Ac 2 O (900 µl) and pyridine (3 ml). After stirring overnight at room temperature, the solvent was removed in vacuo and the residues were purified by silica gel column chromatography mmol), triethylamine (208 µl, 1.5 mmol) in deutrium oxide (500 µl) were shaken for 1 h and lyophilized. To the residue was added Ac 2 O (300 µl) and pyridine (1 ml) and the reaction mixture was stirred overnight at room temperature. The reaction was concentrated in vaccuo and the product was isolated by reverse phase chromatography (12g of C18 column, 50 ml of H 2 O, then 100 ml of acetonitrile). The acetonitrile fraction was concentrated in vacuo then lyophilized. To the residues was added sodium methoxide (6 mg, 0.1 mmol) and dry methanol. The reaction mixture was stirred overnight under nitrogen atmosphere. The D-Cellobiose (34 mg, 0.1 mmol), DMC (85 mg, 0.5 mmol), NaN 3 (97 mg, 1.5 mmol), triethylamine (208 µl, 1.5 mmol) in deutrium oxide (500 µl) were shaken for 1 h and lyophilized. To the residue was added Ac 2 O (300 µl) and pyridine (1 ml) and the reaction mixture was stirred overnight at room temperature. The reaction was concentrated in vaccuo and the product was isolated by reverse phase chromatography (12g of C18 column, 50 ml of H 2 O, then 100 ml of acetonitrile). The acetonitrile fraction was concentrated in vacuo then lyophilized. To the residues was added sodium methoxide (6 mg, 0.1 mmol) and dry methanol. The reaction mixture was stirred overnight under nitrogen atmosphere. The reaction mixture was neutralized with acidic resin (DOWEX ® 50WX2), filtered and lyophilized to afford β-D-cellobiosyl azide 1h (30 mg, 82%) as colorless solid. Spectral characteristics of this compound matched the reported data. D-Lactose monohydrade (36 mg, 0.1 mmol), DMC (85 mg, 0.5 mmol), NaN 3 (97 mg, 1.5 mmol), triethylamine (208 µl, 1.5 mmol) in deutrium oxide (500 µl) were shaken for 1 h and lyophilized. To the residue was added Ac 2 O (300 µl) and pyridine (1 ml) and the reaction mixture was stirred overnight at room temperature. The reaction was concentrated in vaccuo and the product was isolated by reverse phase chromatography (12g of C18 column, 50 ml of H 2 O, then 100 ml of acetonitrile). The acetonitrile fraction was concentrated in vacuo then lyophilized. To the residues was added sodium methoxide (6 mg, 0.1 mmol) and dry methanol. The reaction mixture was stirred overnight under nitrogen atmosphere. The reaction mixture was neutralized with acidic resin (DOWEX ® 50WX2), filtered and lyophilized to afford β-D-Lactosyl azide (36 mg, 99%) as colorless solid. Spectral characteristics of this compound matched the reported data. 
Fucα1-2Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4Glc-1N 3 (1j)
mmol), DMC (8.5 mg, 0.05 mmol), NaN 3 (8.0 mg, 0.125 mmol), triethylamine (10.4 µl, 0.075 mmol) in deutrium oxide (100 µl) were shaken for 8 h and lyophilized. To the residue was added Ac 2 O (50 µl) and pyridine (150 µl) and the reaction mixture was stirred overnight at room temperature. The reaction was concentrated in vaccuo and the product was isolated by reverse phase chromatography (1g of C18 column, 5 ml of H 2 O, then 10 ml of acetonitrile).
The acetonitrile fraction was concentrated in vacuo then lyophilized. To the residues was added sodium methoxide (2 mg) and dry methanol (100 µl). 3'-Sialyllactose (Neu5Acβ2-3Galβ1-4Glc, 10.0 mg, 0.015 mmol), DMC (25.5 mg, 0.15 mmol), NaN 3 (24 mg, 0.375 mmol), triethylamine (31.2 µl, 0.225 mmol) in deutrium oxide (250 µl) were shaken for 5 h and and lyophilized. To the residue was added Ac 2 O (150 µl) and pyridine (450 µl) and the reaction mixture was stirred overnight at room temperature. The reaction was concentrated in vaccuo and the product was isolated by reverse phase chromatography (2g of C18 column, 10 ml of H 2 O, then 20 ml of acetonitrile). The acetonitrile fraction was concentrated in vacuo then lyophilized. To the residues was added LiOH (2 mg) and methanol:water (1:1, 100 µl) and stirred overnight. The reaction mixture was neutralized with acidic resin (DOWEX ® 50WX2), filtered, washed with water and lyophilized to afford 
Synthesis of glycan-tetrazine probe 3
General procedures Procedure 1 (entry 1-9, Table 1 ) Azido glycan 1 (1.0 eq.) and CuSO 4 (0.2 eq.) were dissolved in water (40 mM). To this solution at 0 ºC was added a solution of sodium ascorbate (2.0 eq.), TBTA (Tris[(1-benzyl-1,2,3-triazol-4-yl)methyl]amine, 0.2 eq.) in DMF:t-BuOH (20mM) followed by the alkyne 2 (1.0 eq.) was added to the reaction mixture and stirred at 0ºC for 5 h. The reaction mixture was directly loaded on a column for reverse phage purification (column: SNAP Cartridge KP-C18-HS 60g, flow rate: 35ml/min with collection based on UV detection) to afford the triazole product 3.
Procedure 2 (used for smaller scale reaction, entry 10-12, Table 1 )
Azido glycan 1 (1.0 eq.) and CuSO 4 (2 mg, 12 mM) were dissolved in water (200 µl). To the mixture were added sodium ascorbate (14 mg, 120 mM), TBTA (Tris[(1-benzyl-1,2,3-triazol-4-yl)methyl]amine, 4 mg, 12 mM), DMF (200 µl), t-BuOH (200 µl) and the mixture was kept at 0 ºC. Alkyne 3 (9 mg, 60 mM) was added to the reaction mixture and stirred at 0ºC for 5 h and the reaction was lyophilized. The residues were dissolved in water (200 µl) and the precipitates were removed by centrifugation. Purification by HPLC (column: ZORBAX 300SB-C18 column (9.4 x 250 mm), flow rate : 3 ml/min) afforded the triazole product.
Tetrazine-glucose conjugate 3a
β-D-Glucopyranosyl azide 1a (10 mg, 0.1 mmol) was used following procedure 1. Reverse phase purification (eluent: acetonitrile/water=1/4) afforded conjugate 3a (18 mg, 80%) as red solid. 
Tetrazine-fucose conjugate 3d
β-L-Fucopyranosyl azide 1d (9 mg, 0.05 mmol) was used following procedure 1. Reverse phase purification (eluent: acetonitrile/water=1/4) afforded conjugate 3d (15 mg, 72%) as red solid. 
Tetrazine-cellobiose conjugate 3h
β-D-Cellobiosyl azide 1h (20 mg, 0.05 mmol) was used used following procedure 1. Reverse phase purification (eluent: acetonitrile/water=1/4) afforded conjugate 3h (24 mg, 72%) as red solid. 
Tetrazine Fucα1-2Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4Glc conjugate 3j
β-lacto-N-difucohexaosy azide 1j (4.0 mg, 0.0039 mmol) was used following procedure 2. 
Synthesis of 3-GluNAc-Cy3
N-CY3-Glucosamine (S4)
To the mixture C33-COOH S3 (41 mg, 0.072 mmol) and 2.6-lutidine (10 µl, 0.087 mmol) in dry DMF (0.5 ml) was added HATU (33 mg, 0.087 mmol) at 0 ºC and reaction mixture was stirred for 5 min. Glucosamine hydrochloride (23 mg, 0.107 mmol) was added and the reaction was stirred for 1 h at 0 ºC. The mixture was directly loaded on a reverse phase column for purification (eluent: acetonitrile/water=3/7) to afford S4 (42 mg, 80%) as red solid. 
N-CY3-Glucosamine-azide (S5)
Compound S4 (30 mg, 0.041 mmol), NaN 3 (24 mg, 0.37 mmol) and triethylamine (51 µl, 0.37 mmol) in water (125 µl) and 1.4-dioxane (125 µl) were treated with DMC (35 mg, 0.21 mmol) and the reaction mixture was shaken for 1 h. The crude mixture was directly loaded on a reverse phase column (eluent: acetonitrile/water=3/7) to afford S5 (24 mg, 78%) as red solid. 
3-GluNAc-Cy3
SI--１７
Compound S5 (24 mg, 0.03 mmol), CuI (12 mg, 0.06 mmol), TBTA (2 mg, 0.003 mmol) were taken up in DMF (1 ml) at 0 ºC and alkyne 3 (11 mg, 0.04 mmol) was added. The reaction was stirred for 5 h at 0 ºC and the crude reaction mixture was loaded directly on a reverse phase column (eluent: acetonitrile/water=2/3) to afford 3-GluNAc-Cy3 (4 mg, 11%) as red solid. 
Synthesis of trans-cyclooctene derivative S7 for kinetic study (Z)-cyclooct-4-en-1-ylmethanol (S7)
Compound S6 [5] (1.1 g, 8.15 mmol) in CH 2 Cl 2 (33 ml) was treated dropwise with diisobutylalminium hydride (1.0 M in toluene, 12.2 ml, 12.2 mmol) at -78 ºC and stirred for 1 h under nitrogen atmosphere. The reaction mixture was warmed up to 0 ºC and 2 M HCl (20 ml) was added dropwise to the reaction mixture. The mixture was stirred for another 30 min at room temperature then the organic compounds were extracted with ethyl acetate, washed with brine, dried over Na 2 SO 4 , filtrated and concentrated in vacuo. The residue were taken up 
(E)-(cyclooct-4-en-1-ylmethoxy)triethylsilane (S9)
According to the previously reported procedure, [7] to chlorodiphenylphosphine (723 µl, 4.0 mmol) in dry THF (5 ml) was slowly added lithium wire (62 mg, 8.8 mmol) washed in dry THF (5 ml). The mixture was stirred vigorously at room temperature overnight to give dark red lithium diphenylphosphide solution. This solution was added to S8 (471 mg, 1.74 mmol) dissolved in a few drops of THF and the reaction mixture was stirred for 2 d at room
temperature (the color changed to pale yellow). The reaction mixture was cooled to 0 ºC and AcOH (251 µl, 4.4 mmol) followed by 35% H 2 O 2 (466 µl, 4.8 mmol) were slowly added to the stirring for 1 h at room temperature. The organic compounds were extracted with CH 2 Cl 2 , washed with brine, dried over Na 2 SO 4 , filtrated and concentrated in vacuo. To the residue dissolved in DMF (10 ml) were added to NaH (<60%, 209 mg, 5.22 mmol, washed with dry hexane before using) and stirred for 1 h at room temperature. The reaction was quenched with saturated NH 4 Cl and the organic compounds were extracted with ethyl acetate, washed with brine, dried over Na 2 SO 4 , filtrated and concentrated in vacuo. Purification by silica gel column chromatography (pentane : ethyl acetate = 10 : 1) gave S9 (113 mg, 26%, mixture of atropisomers) as colorless oil. 
(E)-cyclooct-4-en-1-ylmethanol (S10)
To the mixture of S9 (20 mg, 0.08 mmol) in THF (1 ml) was added tetrabuthylammonium fluoride trihydrate (37 mg, 0.12 mmol) at 0 ºC and reaction mixture was stirred for 1 h at 0 ºC. Water was added to the reaction mixture and the organic compounds were extracted with ethyl acetate, washed with brine, dried over Na 2 SO 4 , filtrated and concentrated in vacuo. Purification by silica gel column chromotography (pentane : ethyl acetate = 10 : 1) gave S10 (5 mg, 50%, mixture of atropisomers) as colorless oil. 
Kinetic study of tetrazine-TCO cycloaddition
Kinetic studies of tetrazine-trans-cyclooctene (TCO) cycloaddition were performed by monitoring the change in CY3 fluorescence resulting from the cycloaddition [8] (Figure SI1) . 
Protein conjugation with purified sfGFP-TCOK
Purified sfGFP-TCOK and sfGFP-BocK were obtained according to published protocols. [8] The mixture of sfGFP-TCOK (13.5 µM in Tris buffer pH 7.4, 5 µl) and 3-GluNAc-Cy3 (1 mM in DMSO, 0.68 µl) was incubated for 12 h at 37 ºC. The mixture of sfGFP-BocK (13.5 µM in Tris buffer pH 7.4, 10 µl) and 3-GluNAc-Cy3 (1 mM in DMSO, 1.36 µl) were also incubated as control experiment. Each sample was mixed with NuPAGE lithum dodecyl sulfate (LDS) sample buffer and analyzed by 4-12 % SDS-PAGE. The gel was scanned with Ettan DIGE Imager to visualize in-gel flurorescence and stained by silver-staining. The completion of conjugation was assayed by MALDI-TOF sass spectroscopy.
Purified sfGFP-BCNK were prepared according to published protocols. [8] To the solution of sfGFP-BCNK in Tris buffer pH 7.4 (13.5, 1, 0.1 µM, respectively) was added tetrazine-glycan at 10 equivalents (entry 1) or 5 equivalents (entry 2-4) and the solution was incubated for 10 min at room temperature with gentle agitation on an orbital shaker. The reaction was quenched by addition of 100 eq. of TCO-OH S10 and the product was analyzed by MALDI-TOF. The same procedure was performed for azide-glycan (entry 5) for 10 min and 3 hours and the reaction was quenched by addition of 100 eq. of tetrazine 2 instead of TCO-OH S10.
Protein modification of E. coli expressing sfGFP-TCOK
E. coli pellet (50 µl) expressing sfGFP-TCOK or sfGFP-BocK were obtained as previously described from 3 mL of culture. [8] The pellets were washed 3x with PBS to remove excess TCOK or BOCK. An aliquot of each E. coli pellet (15 µl) were treated with 100 µl of a 25 µM solution of 3-GluNAc-Cy3 in PBS buffer and incubated for 8h at room temperature with gentle agitation on an orbital shaker. The E. coli were re-pelleted by centrifugation and washed twice with PBS (centrifuge and discard supernatant). Then, 30 µl of LDS buffer was added to the pellet and the mixture was incubated for 10 min at room temperature. The 
